Pharmacologic characterization of immune complex induced bronchoconstriction in guinea pigs.
Intravenous injections of soluble immune complexes to anesthetized guinea pigs resulted in bronchoconstriction that was inhibited by FPL 55712, indomethacin, oxarbazole, soybean trypsin inhibitor, and cobra venom factor. Immune complex induced bronchoconstriction was not inhibited by atropine, imidazole, mepyramine, ketotifen, methysergide, and the anti-anaphylactic compound DPP (Diethyl [2-(4-pyridyl)-4-pyrimidinyl]aminoethylene malonate). Immune complex induced bronchoconstriction in guinea pigs appears to involve activation of complement and formation of anaphylatoxins. In addition, products of cyclo-oxygenase metabolism of arachidonic acid and kinins may be involved.
D000403:Airway Resistance / Q000187:drug effects*; D000706:Anaphylatoxins / Q000494:pharmacology; D000707:Anaphylaxis / Q000503:physiopathology; D000818:Animals; D001980:Bronchi / Q000187:drug effects / Q000503:physiopathology; D016861:Cyclooxygenase Inhibitors; D005260:Female; D006168:Guinea Pigs; D007105:Immune Complex Diseases / Q000503:physiopathology*; D007705:Kinins / Q000502:physiology
D000706:Anaphylatoxins; D016861:Cyclooxygenase Inhibitors; D007705:Kinins